Skip to Content
 

VICC toll-free number 1-877-936-8422

Head and Neck Cancers

Although head and neck cancer is a common malignancy, there are few programs in the country that have dedicated, multidisciplinary teams to treat a large number of patients. The Vanderbilt-Ingram Cancer Center has a nationally recognized Head and Neck Cancer Program which is staffed by expert surgeons, a full-time medical oncologist and full-time radiation oncologists.

Clinical Trials for Head and Neck Cancers

12 Open Trials

Trial Type Protocol No. &
Open Date
Summary

Basic Science

VICCHN0356

02/04/2003

Head and Neck Tumor Tissue Repository and Clinical Database

Health Services Research

VICCHN1533

09/28/2016

Characterization of Cardiac Function, Pulmonary Function, and Body Composition Before and After Concurrent Chemoradiotherapy for Head and Neck Cancer

Other

VICCHN17101

08/15/2017

Advancing New Modalities for the Detection of Oropharyngeal Cancer: Transcervical Ultrasound and HPV16 E6 Antibodies

Other

VICCHN15135

09/28/2016

Assessing Skin/Soft Tissue Elasticity in Head and Neck Cancer Survivors

Supportive Care

VICCSUPP1529

06/08/2015

Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients

Treatment

VICCHN1776

01/02/2018

A Pilot Study to Evaluate the Feasibility and Potential Effectiveness of the Flexitouch? System Head and Neck Treatment

Treatment

VICCPHI1748

11/09/2017

A Phase I, Open-label, Uncontrolled, Multicenter, Dose-escalation Study of M3541 in Combination with Palliative Radiotherapy in Subjects with Solid Tumors

Treatment

VICCHN16122

07/25/2017

A Randomized Double-Blind Phase 3 Study of Avelumab in Combination with Standard of Care Chemoradiotherapy (Cisplatin plus Definitive Radiation Therapy) versus Standard of Care Chemoradiotherapy in the Front-Line Treatment of Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Treatment

VICCMD1636

12/21/2016

A Phase 1b/2 Open-Label Study to Evaluate Safety, Clinical Activity, Pharmacokinetics and Pharmacodynamics of Avelumab (MSB0010718C) in Combination with Other Cancer Immunotherapies in Patients with Advanced Malignancies

Treatment

VICCMD15110

04/05/2016

A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors

Treatment

VICCPHI1531

03/01/2016

A Phase 1/2 Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers

Treatment

ECOGHNE1305-M

02/11/2009

A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer